Evidence map›Paper›PMID 30535405›Full record

ArticleGigaScience2019

PhenoMeNal: processing and analysis of metabolomics data in the cloud.

Kristian Peters, James Bradbury, Sven Bergmann, Marco Capuccini, Marta Cascante, Pedro de Atauri, Timothy M D Ebbels, Carles Foguet, Robert Glen, Alejandra Gonzalez-Beltran and 46 more

Abstract read
In one paragraph

Article in GigaScience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Metabolomics of neurological disorders in India.Analytical science advances · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Kristian PetersLeibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
James BradburySchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Sven BergmannDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Marco CapucciniDivision of Scientific Computing, Department of Information Technology, Uppsala University, Sweden.
Marta CascanteDepartment of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
Pedro de AtauriDepartment of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
Timothy M D EbbelsDepartment of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Carles FoguetDepartment of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
Robert GlenDepartment of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Alejandra Gonzalez-BeltranOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
Ulrich L GüntherInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Evangelos HandakasDepartment of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Thomas HankemeierDivision of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, 2333 CC, The Netherlands.
Kenneth HaugEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Stephanie HermanDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
Petr HolubBBMRI-ERIC, Graz, Austria.
Massimiliano IzzoOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
Daniel JacobINRA, University of Bordeaux, Plateforme Métabolome Bordeaux-MetaboHUB, 33140 Villenave d'Ornon, France.
David JohnsonOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
Fabien JourdanINRA - French National Institute for Agricultural Research, UMR1331, Toxalim, Research Centre in Food Toxicology, Toulouse, France.
Namrata KaleEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Ibrahim KaramanDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St. Mary's Campus, Norfolk Place, W2 1PG, London, United Kingdom.
Bita KhaliliDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Payam Emami KhonsariDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
Kim KultimaDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
Samuel LampaDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
Anders LarssonDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
Christian LudwigInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Pablo MorenoEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Steffen NeumannLeibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
Jon Ander NovellaDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
Claire O'DonovanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Jake T M PearceDepartment of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Alina PelusoDepartment of Surgery & Cancer, Imperial College London, South Kensington, London, SW7 2AZ, United Kingdom.
Marco Enrico PirasDistributed Computing Group, CRS4, Pula, Italy.
Luca PiredduDistributed Computing Group, CRS4, Pula, Italy.
Michelle A C ReedInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Philippe Rocca-SerraOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
Pierrick RogerCEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB, Gif-Sur-Yvette F-91191, France.
Antonio RosatoMagnetic Resonance Center (CERM) and Department of Chemistry, University of Florence and CIRMMP, 50019 Sesto Fiorentino, Florence, Italy.
Rico RueediDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Christoph RuttkiesLeibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
Noureddin SadawiDepartment of Computer Science, College of Engineering, Design and Physical Sciences, Brunel University, London, UK.
Reza M SalekEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Susanna-Assunta SansoneOxford e-Research Centre, Department of Engineering Science, University of Oxford, 7 Keble Road, OX1 3QG, Oxford, United Kingdom.
Vitaly SelivanovDepartment of Biochemistry and Molecular Biomedicine, Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Spain.
Ola SpjuthDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden.
Daniel SchoberLeibniz Institute of Plant Biochemistry, Stress and Developmental Biology, Weinberg 3, 06120 Halle (Saale), Germany.
Etienne A ThévenotCEA, LIST, Laboratory for Data Analysis and Systems' Intelligence, MetaboHUB, Gif-Sur-Yvette F-91191, France.
Mattia TomasoniDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Merlijn van RijswijkNetherlands Metabolomics Center, Leiden, 2333 CC, Netherlands.
Michael van VlietDivision of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, 2333 CC, The Netherlands.
Mark R ViantSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Ralf J M WeberSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.
Gianluigi ZanettiDistributed Computing Group, CRS4, Pula, Italy.
Christoph SteinbeckCheminformatics and Computational Metabolomics, Institute for Analytical Chemistry, Lessingstr. 8, 07743 Jena, Germany.

Funding

Biotechnology and Biological Sciences Research Council BB/H024921/1Biotechnology and Biological Sciences Research Council BB/I000771/1Medical Research Council MR/M009157/1
6 · The paper itself

Abstract

backgroundMetabolomics is the comprehensive study of a multitude of small molecules to gain insight into an organism's metabolism. The research field is dynamic and expanding with applications across biomedical, biotechnological, and many other applied biological domains. Its computationally intensive nature has driven requirements for open data formats, data repositories, and data analysis tools. However, the rapid progress has resulted in a mosaic of independent, and sometimes incompatible, analysis methods that are difficult to connect into a useful and complete data analysis solution.

findingsPhenoMeNal (Phenome and Metabolome aNalysis) is an advanced and complete solution to set up Infrastructure-as-a-Service (IaaS) that brings workflow-oriented, interoperable metabolomics data analysis platforms into the cloud. PhenoMeNal seamlessly integrates a wide array of existing open-source tools that are tested and packaged as Docker containers through the project's continuous integration process and deployed based on a kubernetes orchestration framework. It also provides a number of standardized, automated, and published analysis workflows in the user interfaces Galaxy, Jupyter, Luigi, and Pachyderm.

conclusionsPhenoMeNal constitutes a keystone solution in cloud e-infrastructures available for metabolomics. PhenoMeNal is a unique and complete solution for setting up cloud e-infrastructures through easy-to-use web interfaces that can be scaled to any custom public and private cloud environment. By harmonizing and automating software installation and configuration and through ready-to-use scientific workflow user interfaces, PhenoMeNal has succeeded in providing scientists with workflow-driven, reproducible, and shareable metabolomics data analysis platforms that are interfaced through standard data formats, representative datasets, versioned, and have been tested for reproducibility and interoperability. The elastic implementation of PhenoMeNal further allows easy adaptation of the infrastructure to other application areas and 'omics research domains.

Indexed as

SoftwareCloud ComputingHumansMetabolomicsWorkflowcloud computingcomputational workflowsdata analysise-infrastructuresgalaxymass spectrometrymetabolomicsNMRstandardizationstatistics

Identifiers

PMID30535405
PMCPMC6377398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.